615O - Safety and preliminary efficacy of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (aHCC): Interim analysis of the phase 1/2 CheckMate-040 study
Autor: | Melero, I., Sangro, B., Yau, T., Hsu, C., Kudo, M., Crocenzi, T., Kim, T.-Y., Choo, S.-P., Trojan, J., Meyer, T., Welling, T.H., III, Yeo, W., Chopra, A., Anderson, J., De Cruz, C.l.a., Lang, L., Neely, J., El-Khoueiry, A. |
---|---|
Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi209-vi209 |
Databáze: | ScienceDirect |
Externí odkaz: |